Showing results (1-10 of 388) with videos related to

Sort By:
Pageof 39
Exploration of Targeted Anti-Tumor Therapy|March 21, 2022
B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cellsAnnabel R Minton, Lindsay D Smith, Dean J Bryant, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Current strategies for the design of PROTAC linkers: a critical reviewRobert I Troup, Charlene Fallan, Matthias G J Baud
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkersGiovanni Vicidomini, Roberto Cascone, Annalisa Carlucci, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
The evolving role and utility of off-label drug use in multiple myelomaJames H Stoeckle, Faith E Davies, Louis Williams, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Yeast as a tool to decipher the molecular mechanisms underlying the functions of Bcl-2 familyStéphen Manon
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Antibody-drug conjugates: beyond current approvals and potential future strategiesSiddharth Menon, Sagun Parakh, Andrew M Scott, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Current options and future directions of systemic therapy for advanced biliary tract cancerMaria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancerAlfredo Rossi, Gemma Caro, Francesca Magri, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
A novel strategy for treating cancer: understanding the role of Ca2+ signaling from nociceptive TRP channels in regulating cancer progressionWen-Li Hsu, Mami Noda, Tohru Yoshioka, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting itPrasad Sulkshane, Tanuja Teni
Pageof 39